Optic Neuropathy (overview).pptx

muneeb252 216 views 36 slides Jan 22, 2023
Slide 1
Slide 1 of 36
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36

About This Presentation

Optic neuroptahy by Dr Muneeb


Slide Content

Overview of optic neuropathy Dr Khuda bukhsh saleemi PGR1 Ophthalmology

Optic Nerve

Anatomical SUbdivisions

Optic Neuropathy is damage to the optic nerve from any cause

Causes

CLINICAL APPROACH History 1. The MODE OF ONSET of visual loss is an important clue to the etiology of the optic neuropathy. i.e. Rapid onset is characteristic of optic neuritis, ischemic optic neuropathy, inflammatory (non-demyelinating) and traumatic optic neuropathy. Gradual onset over months is typical of compressive toxic/nutritional optic neuropathy. History over years is seen in compressive and hereditary optic neuropathies.

CLINICAL APPROACH 2. ASSOCIATED SYMPTOMS In young patient H/O pain associated with eye movement, paresthesia, limb weakness, and ataxia is suggestive of demyelinating optic neuritis. In elderly patients transient visual loss, diplopia, temporal pain, jaw claudication, fatigue, weight loss and myalgia suggestive of AION.

CLINICAL APPROACH Symptoms such as diplopia and facial pain are suggestive of multiple cranial neuropathies seen in inflammatory or neoplastic lesions of the posterior orbit or parasellar region. Transient diplopia and headache should raise the suspicion of increased intra-cranial pressure.

CLINICAL APPROACH 3. DRUG HISTORY Ethambutol, amiodarone, alcohol Immunosuppressive medications such as methotrexate and Cyclosporine 4. MEDICAL HISTORY DM, HTN and hypercholesterolemia is common in patients with nonarteritic ischemic optic neuropathy (NAION).

Optic neuritis

Optic neuritis Symptoms: Monocular (Central Vision loss) •Pain (eye movement) •Altered colour vision •Flashes

Physical Signs

Treatment Steroid regimen I/V methylprednisolone sodium succinate 1 g daily for 3 days, followed by oral prednisolone (1 mg/kg daily) for 11 days, subsequently tapered over 3 days. Other immunomodulatory treatment options Interferon beta teriflunomide

Other Inflammatory Causes

Non ARTERITIC anterior Ischemic Optic Neuropathy ( NaAION ) Caused by occlusion of the short posterior ciliary arteries resulting in partial or total infarction of the optic nerve head. Risk Factors Age > 50 yr Structural crowding of optic nerve head Hypertension Diabetes Mellitus Hyperlipidaemia Collagen vascular disease

NaAION Symptoms: Sudden painless monocular visual loss; this is frequently discovered on awakening Signs: moderate to severe visual impairment Visual field defects are typically inferior altitudinal Dyschromatopsia is usually proportional to the level of visual impairment Diffuse or sectoral hyperaemic disc swelling

NaAION Investigations: blood pressure fasting lipid profile blood glucose

NaAION Treatment: There is no definitive treatment Any underlying systemic predispositions should be treated Aspirin is effective in reducing systemic vascular events Aspirin is frequently prescribed in patients with NAION

ARTERITIC ANTERIOR ISCHAEMIC OPTIC NEUROPATHY (AAION)

OCCULAR SIGNS OF AAION

ARTERITIC ANTERIOR ISCHAEMIC OPTIC NEUROPATHY (AAION) Diagnostic work up Erythrocyte sedimentation rate (ESR) >47mm C-reactive protein >2.45 mg/dL Fluorescein fundus angiographic (FFA): Critical diagnostic test for A-AION during the early stages  shows thrombosis and occlusion of the posterior ciliary artery in GCA Temporal Artery Biopsy Clinical Signs: Jaw Claudication, Neck Pain

ARTERITIC ANTERIOR ISCHAEMIC OPTIC NEUROPATHY (AAION) Treatment: (steroid therapy) It is aimed at preventing blindness of the fellow eye High dose systemic corticosteroid (IV methylprednisolone & oral prednisolone) for several months. Intravenous methylprednisolone, 500 mg to 1 g/day for 3 days followed by oral prednisolone 1–2 mg/kg/day. After 3 more days the oral dose is reduced to 50–60 mg (not less than 0.75 mg/kg) for 4 weeks or until symptom resolution and ESR/CRP normalization. Prognosis-POOR

Traumatic Optic Neuropathy

Diagnosis CT scan of the orbit is recommended to detect any bony fractures, fractures of the optic canal,and acute orbital hemorrhages

Traumatic Optic Neuropathy Treatment: High-dose steroid therapy Was adopted as a treatment because of their beneficial effect in studies on spinal cord injuries. May be harmful to the optic nerve if started 8 hours after the injury

Infiltrative optic neuropathy

Compressive Optic Neuropathy

Hereditary optic neuropathies

Nutritional optic neuropathies

Toxic optic neuropathies

Field Defects of Optic Neuropathies Demyelinating Central, cecocentral, arcuate Non-arteritic Ischemic Arcuate, altitudinal Arteritic Ischemic Arcuate Inflammatory Arcuate, central, cecocentral Hereditary Central, cecocentral Traumatic Arcaute, central or hemianopic Infiltrative Arcuate, hemianopic Compressive Arcuate, hemianopic Toxic/nutritional Central, cecocentral

T hank you
Tags